Profit and Loss Results Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 4.15% vs 3.19% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 16.22% vs 34.19% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 40.68% vs 10.23% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is 21.74% vs 14.49% in Mar 2024
Compare Profit and Loss Results of Medico Remedies
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
150.00
345.00
-195.00
-56.52%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
150.00
345.00
-195.00
-56.52%
Expenditure (Ex Depriciation)
Stock Adjustments
-5.00
-14.00
9.00
64.29%
Raw Materials Consumed
113.00
130.00
-17.00
-13.08%
Power & Fuel Cost
2.00
14.00
-12.00
-85.71%
Employee Cost
6.00
109.00
-103.00
-94.50%
Operating Expenses
7.00
9.00
-2.00
-22.22%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
6.00
36.00
-30.00
-83.33%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
18.00
-18.00
-100.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
135.00
342.00
-207.00
-60.53%
Operating Profit (PBDIT) excl Other Income
15.00
3.00
12.00
400.00%
Other Income
2.00
29.00
-27.00
-93.10%
Operating Profit (PBDIT)
17.00
32.00
-15.00
-46.88%
Interest
1.00
0.00
1.00
0%
Profit before Depriciation and Tax
16.00
32.00
-16.00
-50.00%
Depreciation
3.00
6.00
-3.00
-50.00%
Profit Before Taxation & Exceptional Items
13.00
25.00
-12.00
-48.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
13.00
25.00
-12.00
-48.00%
Provision for Tax
3.00
8.00
-5.00
-62.50%
Profit After Tax
10.00
17.00
-7.00
-41.18%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
32.00
238.00
-206.00
-86.55%
Profit Available for appropriations
42.00
255.00
-213.00
-83.53%
Appropriations
42.00
255.00
-213.00
-83.53%
Equity Dividend (%)
0%
50%
-50.00
Earnings Per Share
1.22
30.14
-28.92
-95.95%
Profit And Loss - Net Sales
Net Sales 150.94 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 4.15% vs 3.19% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 15.00 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 16.22% vs 34.19% in Mar 2024
Profit And Loss - Interest
Interest 1.16 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 40.68% vs 10.23% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 10.09 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 21.74% vs 14.49% in Mar 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
